Learning objectives: Recognize OUD as chronic, remitting-recurring neurobehavioral disorder.

Explain the rationale for medication treatment and its effectiveness in reducing overdose mortality.

Session date: 
10/23/2018 - 12:00pm to 1:00pm CDT
Chicago, IL 60637
United States
  • 1.00 AMA PRA Category 1 Credit™
  • 1.00 Participation

Please login or create an account to proceed.
Speaker Name: 
Peter D. Friedmann, MD, MPH, FASAM, FACP